The largest single-center study of depression in amyotrophic lateral sclerosis yields practice-shaping findings on depression’s prevalence and effects on survival and quality of life.
While we have long been able to analyze the financial impact of screening options and therapies, there now are tools that can help providers analyze the effects of their efforts.
Patients with epilepsy and multiple sclerosis have high rates of depression and an increased risk for suicide. Cleveland Clinic analysis shows the PHQ-9 can be useful in identifying who may benefit from psychiatric care.
An initiative that encourages patients to enter information on their own condition into portable tablet devices is enhancing the electronic medical record and putting big data to use.
As routine psychosocial screening of oncology patients for distress becomes required for accreditation, Cleveland Clinic has developed a system that uses an EMR-integrated screening tool to assess all patients at check-in.
Cleveland Clinic’s Knowledge Program allows physicians to identify depression and other neuropsychiatric conditions in children with epilepsy and initiate earlier treatments.
Cleveland Clinic increasingly draws on a scalable platform developed to collect data from patients and providers as it seeks to understand what constitutes a clinically meaningful change in health status measures.
Some long-standing beliefs about spine care appear to be cracking under the weight of robust outcomes tracking made possible by Cleveland Clinic’s Knowledge Program data collection tool.